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Abstract 
Background 
By regulating digestion and absorption of nutrients and providing a barrier against the 
external environment the intestine provides a crucial contribution to the maintenance of 
health. To what extent aging-related changes in the intestinal system contribute to the 
functional decline associated with aging is still under debate. 
Methods 
Young (4 M) and old (21 M) male C57BL/6 J mice were fed a control low-fat (10E%) or a 
high-fat diet (45E%) for 2 weeks. During the intervention gross energy intake and energy 
excretion in the feces were measured. After sacrifice the small and large intestine were 
isolated and the small intestine was divided in three equal parts. Swiss rolls were prepared of 
each of the isolated segments for histological analysis and the luminal content was isolated to 
examine alterations in the microflora with 16S rRNA Q-PCR. Furthermore, mucosal 
scrapings were isolated from each segment to determine differential gene expression by 
microarray analysis and global DNA methylation by pyrosequencing. 
Results 
Digestible energy intake was similar between the two age groups on both the control and the 
high-fat diet. Microarray analysis on RNA from intestinal scrapings showed no marked 
changes in expression of genes involved in metabolic processes. Decreased expression of 
Cubilin was observed in the intestine of 21-month-old mice, which might contribute to aging-
induced vitamin B12 deficiency. Furthermore, microarray data analysis revealed enhanced 
expression of a large number of genes involved in immune response and inflammation in the 
colon, but not in the small intestine of the 21-month-old mice. Aging-induced global 
hypomethylation was observed in the colon and the distal part of the small intestine, but not 
in the first two sections of the small intestine. 
Conclusion 
In 21-month old mice the most pronounced effects of aging were observed in the colon, 
whereas very few changes were observed in the small intestine. 
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Background 
The most well established functions of the small intestine are the digestion of food and 
absorption of nutrients. The main functions of the colon are the absorption of water and 
electrolytes and provide a reservoir for the fermentation of undigested macronutrients. To 
protect the body against detrimental invaders from the outside world, the intestine is armed 
with a complex and robust immune system [1,2]. The colon is also host to a broad variety of 
microorganisms that not only are responsible for the fermentation of undigested nutrients and 
the synthesis of essential vitamins, but also play a crucial role in the establishment of a proper 
immune system in postnatal life [1]. Recently, we have shown that physiological adaptations 
in the small intestine to dietary challenges may play a causal role in the development of 
diseases such as obesity and/or insulin resistance [3]. 
To enable these exclusive functions, the intestine has a unique and highly specialized tissue 
structure. A high efficiency of digestion and absorption is made possible by an enormous 
surface area created by intestinal folds, villi, microvilli, crypts and the glycocalyx in the small 
intestinal lumen. This large surface area facilitates optimal contact between food and 
digestive enzymes and creates a huge capacity for active and passive up-take of nutrients. In 
contrast to the small intestine, in the colon the increase in the surface area is realized by 
microvilli and crypts. The enormous contact area at the same time increases the risk of 
infections by either pathogens entering the body via the diet or by enteric commensal bacteria 
colonizing the intestinal lumen. Protection against invading microorganisms is provided by 
several defense mechanisms. Besides a mucous layer present on top of a continues layer of 
epithelial cells covering the surface of the intestine, a wide variety of immunological cells 
and tissue structures are present in the mucosa and submucosa of the intestinal wall [1,4,5]. 
Like all organs, the gastrointestinal tract does not escape the adverse effects of aging and 
various anomalies related to the digestive system occur with increasing frequency in our 
rapidly aging Western society. Impaired taste sensation, problems with swallowing, slower 
gastric emptying and intestinal and colonic transit, and altered levels of satiety hormones 
have been reported in the elderly [6-10]. To what extent impaired functioning of the small 
and large intestine contributes to the undernourished state often observed in the elderly is 
currently under debate. Aging-induced morphological [11-13] as well as functional changes 
in the intestine have been reported [8,14,15]. However, since these effects are often very 
subtle and the intestinal system has a highly adaptive and extensive reserve capacity [14], it is 
still questionable whether these changes play a role in aging-related malnutrition. 
Furthermore, it has been shown that aging can cause bacterial overgrowth in the small 
intestine [16,17] and promote changes in microbial composition in the colon [18-20]. In 
addition, reported age-related changes in DNA methylation of the mouse intestine [21] might 
play a role in the altered gene expression levels observed in the duodenum and colon of aging 
mice [22]. Together these observations demonstrate that although certain aspects of the aging 
intestine have been studied in a variety of independent studies, a comprehensive overview of 
the different features of the aging intestine is still lacking. Such a comprehensive study may 
prove essential to our understanding of how intestinal malfunction contributes to the 
undernourished condition often observed in the elderly. 
In this study, we have carried out a detailed comparison of functional, structural and 
molecular features of the small intestine and the colon of 4- and 21-month-old male C57BL/6 
J mice. Mice of both age groups were exposed for two weeks to a low-fat or a high-fat diet to 
analyze the adaptive capacity of the intestine. During the intervention period body weight and 
the efficiency of energy up-take were measured. After sacrifice the small intestine and colon 
were isolated to analyze tissue morphology, luminal bacterial content and mucosal gene 
expression and DNA methylation. The results obtained in this study imply that at the age of 
21 months, the intestine of C57BL/6 J mice is functionally and structurally remarkably 
comparable to that of their 4-month-old counterparts. On a molecular level the main age-
related changes in 21-month-old mice were found in the third part of the small intestine, and 
in particular in the colon. 
Methods 
Ethics statement 
The institutional and national guidelines for the care and use of animals were followed and 
the experiment was approved by the Local Committee for Care and Use of Laboratory 
Animals at Wageningen University (code number: drs-2010048b). 
Animals and diets 
Male C57BL/6 J mice (age 2,5 and 19 months) were purchased from Janvier (Cedex, France) 
and were housed individually in the light and temperature-controlled animal facility (12/12 
(light/dark), 20 °C) of Wageningen University. The mice had free access to water and 
received standard laboratory chow (RMH-B, Arie Blok BV, Woerden, the Netherlands) for 
12 days, followed by a run-in period for 3 weeks during which all mice received the low-fat 
diet (10E%) to adapt to the purified diets. At the start of the diet intervention, the young mice 
were divided into two groups of 6 mice and the old mice into two groups of 8 mice. A larger 
number of old mice were used to compensate for potential loss due to aging but none of the 
mice died during the experiment. Of each age group, half of the mice received a low-fat diet 
while the other half of the mice received a high-fat purified diet, as described in our previous 
study [3]. Both diets were based on Research Diets’ formulas D12450B/D12451, with 
adaptations regarding type of fat (palm oil instead of lard) and carbohydrates (Research diet 
services, Wijk bij Duurstede, The Netherlands). Thus, the high-fat diet mimics the ratio of 
saturated to monounsaturated to polyunsaturated fatty acids (40:40:20) in an average Western 
style human diet. The energy density of all nutrients except fat and starch was equal. After 2 
weeks of diet intervention all mice were anaesthetized with a mixture of isofluorane (1.5 %), 
nitrous oxide (70 %) and oxygen (30 %) in the postprandial state. From all sacrificed mice 
the small intestine and the colon were excised. The small intestine was divided in three equal 
parts, cut open longitudinally and shaken thoroughly in an eppendorf tube containing 1 ml 
PBS to isolate the luminal content. The luminal content of the colon was isolated removing 
the fecal parts with a spatula. After washing the proximal, middle and distal part of the small 
intestine and the colon in PBS Swiss rolls were prepared of the middle part of each segment 
for histomorphological analysis. For mRNA expression analysis and global DNA methylation 
analysis scrapings were made of the mucosa and submucosa of the remaining part of each 
section, snap frozen in liquid nitrogen and stored at -80
0
C. Scrapings were crushed on liquid 
nitrogen and divided into two portions, one for RNA and the other for DNA isolation. 
Energy intake and excretion 
Food intake of each individual mouse was recorded during the run-in and the diet 
intervention period. Feces were collected from individual mice over a period of 24 hours and 
freeze dried after which the total amount of feces per mouse was measured. Energy content of 
the feces was determined with a bomb calorimeter (Isothermal Bomb Calorimeter, Cal2K, 
South Africa). The efficiency of energy intake was calculated by the formula: ((total energy 
intake – total energy exertion)/total energy intake)*100 %. 
RNA isolation 
Total RNA was isolated using TRIzol reagent (Invitrogen Breda, The Netherlands) according 
to the manufacturer’s instructions. The RNA was treated with DNAse and purified on 
columns using the RNAeasy microkit (Qiagen, Venlo, the Netherlands). RNA concentration 
was measured on a NanonDrop ND-1000 UV–vis spectrophotometer (Isogen, Maarsen, The 
Netherlands) and RNA integrity was checked on an Agilent 2100 Bioanalyzer (Agilent 
Technologies, Amsterdam, The Netherlands) with 6000 Nano Chips according to the 
manufacturer’s instructions. RNA was judged as suitable only if samples showed intact bands 
of 18S and 28S ribosomal RNA subunits, displayed no chromosomal peaks or RNA 
degradation products, and had a RNA integrity number (RIN) above 8.0. 
Microarray hybridization and analysis 
Equal amounts of total RNA of all six young mice per diet group were pooled for the 
proximal, middle and distal part of the small intestine respectively and for the colon. For the 
old mice the same procedure was applied, but now all eight mice per diet group were taken. 
One hundred nanogram of pooled RNA was used for Whole Transcript cDNA synthesis 
(Affymetrix, Santa Clara, CA). Hybridization, washing and scanning of Affymetrix 
GeneChip Mouse Gene 1.0 ST arrays were carried out according to standard Affymetrix 
protocols. All arrays of the small intestine were hybridized in one experiment, and all colon 
samples were hybridized together in a second microarray experiment. Data analysis of the 
small intestine and colon was done separately. Arrays were normalized using the Robust 
Multi-array Average method (PMID: 12538238, PMID: 12582260). Probe sets were defined 
according to Dai et al. (PMID: 16284200). In this method probes are assigned to unique gene 
identifiers, in this case Entrez IDs. The probes on the Gene 1.0 ST arrays represent 20,985 
Entrez IDs. For the analysis only genes were taken into account that had an intensity value 
of > 50 on at least one array. Pancreas-specific genes (http://biogps.org) were removed from 
the analysis in order to omit an effect of potential pancreatic contamination. Changes in gene 
expression were calculated as fold change between young and old mice or between a high-fat 
and low-fat diet. For further analysis we used a fold change cut-off of > 2.0 to minimalize the 
inclusion of false positive differentially expressed genes. Array data have been submitted to 
the Gene Expression Omnibus, accession number GSE39975. 
cDNA synthesis and real-time quantitative PCR 
To validate the microarray data and to check for inter-animal variation, RNA’s from 
individual mice were used. For each individual sample, single-stranded complementary DNA 
(cDNA) was synthesized from 1 μg of total RNA using the Reverse transcription system 
(iScript, Biorad) following the supplier's protocol. cDNA was PCR amplified with Platinum 
Taq DNA polymerase (all reagents were from Invitrogen). Primer sequences were retrieved 
from the online PrimerBank database [23], or otherwise designed using the Primer3 program 
[24] and the sequences of the primers used are listed in Table 1. 
Table 1 Sequences of the primers used for Q-PCR analysis 
Gene Sequence forward primer Sequence reverse primer 
INFγ ATGAACGCTACACACTGCATC CCATCCTTTTGCCAGTTCCTC 
IF44 AACTGACTGCTCGCAATAATGT GTAACACAGCAATGCCTCTTGT 
IF47 AGCAGATGAATCCGCTGATGT CGTGGAAATTGGGTGTCCC 
TNFα CAACCTCCTCTCTGCCGTCAA CGTGGAAATTGGGTGTCCC 
IL1β TGGTGTGTGACGTTCCCATT CAGCACGAGGCTTTTTGTTG 
IL6 CTTCCATCCAGTTGCCTTCTTG AATTAAGCCTCCGACTTGTGAAG 
Cubn GAATGTGGCTCCAAGTCCCAT ACGGCTAATGAAGGATGCAGA 
36B4 AGCGCGTCCTGGCATTGTGTGG GGGCAGCAGTGGTGGCAGCAGC 
Primers were tested for specificity by BLAST analysis. Real-time quantitative PCR (Q-PCR) 
was performed using SYBR green and a MyIQ thermal cycler (Bio-Rad laboratories BV, 
Veenendaal, The Netherlands). The following thermal cycling conditions were used: 2 min at 
94 °C, followed by 40 cycles of 94 °C for 15 s and 60 °C for 45 s. PCR reactions to validate 
aging-induced differential gene expression were performed in duplicate and all samples were 
normalized to 36B4 expression. 
Histochemistry 
Four-micrometer sections of paraffin-embedded parts of the proximal, middle and distal 
segment of the small intestine and of the colon were mounted on Superfrost microscope 
slides. These sections were dewaxed in xylene and rehydrated in a series of graded alcohols. 
After staining with Meyer's hematoxylin/eosine sections were mounted with DePex mounting 
medium (Gurr, BDH, Poole, Dorset, UK). 
Bacterial DNA extraction 
DNA was extracted from the freeze-dried luminal content of the 4 sections of the intestine 
using the method described by Salonen et al. [25]. In short, approximately 0.1 g was used for 
mechanical and chemical lysis using 0.5 ml buffer (500 mM NaCl, 50 mM Tris–HCl (pH 8), 
50 mM EDTA, 4 % SDS) and 0.25 g of 0.1 mm zirconia beads and 3 mm glass beads. 
Nucleic acids were precipitated by addition of 130 μl, 10 M ammonium acetate, using one 
volume of isopropanol. Subsequently, DNA pellets were washed with 70 % ethanol. Further 
purification of DNA was performed using the QiaAmp DNA Mini Stool Kit (Qiagen, Hilden, 
Germany). Finally, DNA was dissolved in 200 μl Tris/EDTA buffer and its purity and 
quantity were checked spectrophotometrically (ND-1000, nanoDrop technologies, 
Wilmington, USA). 
16S rRNA Q-PCR 
To quantify total bacteria using 16 S rRNA-specific primers Q-PCR analysis was in carried 
out as described above with a few modifications. The used primer sequence used were: The 
Q-PCR conditions used were: 95 °C for 10 min, followed by 35 cycles of denaturation at 95 
°C for 15 sec, annealing temperature of 60 °C for 20 sec, extension at 72 °C for 30 sec and a 
final extension step at 72 °C for 5 min. 
DNA isolation from scrapings of the small intestine and the colon 
Genomic DNA was isolated from the crushed scraping by using DNeasy® Blood and Tissue 
Kit (Qiagen, Venlo, the Netherlands) according to the manufacturer’s instructions. The DNA 
was treated with RNase and eluted in Tris/EDTA buffer (pH 9.0). DNA purity and quantity 
were checked spectrophotometricaly (ND-1000, nanoDrop technologies, Wilmington, USA). 
DNA methylation analysis 
700 ng of genomic DNA for each sample was bisulfite-treated using EZ-96 DNA 
Methylation-Gold
TM
 Kit ( Zymo Research, USA) and eluted in 16 μL of M-Elution Buffer. 
Included in the bisulfite-treatment was a separate methylation curve consisting of a mix of 
low and highly methylated mouse genomic DNA (0 %, 25 %, 50 %, 75 % and 100 % of 
highly methylated DNA (EpigenDx, Worcester, USA)). The B1-element assay was 
performed in a 45 μL PCR reaction containing 6 μL of bisulfite-treated genomic DNA, 
PyroMark PCR Master Mix, CoralLoad Concentrate according to manufacturer’s instructions 
and 0.4 μM of each primer (Qiagen, Venlo, the Netherlands). The following thermal cycling 
conditions were used: 15 min at 95 °C, followed by 45 cycles of 94 °C for 30 s, 54 °C for 
30s, and 72 °C for 40s, followed by a final elongation step at 72 °C for 10 min. The primer 
sequence used for forward and biotinylated reverse primer were 5’-
TTGGTTATTTTGGAATTTATTTTGTAGAT-3’ and 5’-biotin-
TAATAACACACACCTTTAATCCCAACA-3’ respectively. B1-element methylation 
analysis was performed using Pyromark
TM
 pyrosequencing technology (Biotage AB, 
Uppsala, Sweden). The PCR product was purified and made single-stranded using the 
Pyrosequencing Vacuum Prep Tool according to the manufacturer’s instructions (Qiagen, 
Venlo, The Netherlands). Sequencing primer (5’-TTTGGAATTTATTTTGTAGATTAG-3’) 
was annealed to the purified single-stranded PCR product and pyrosequencing was performed 
using the Q24 Pyrosequencing System (Qiagen, Venlo, The Netherlands) and CpG 
methylation was analyzed with the provided software. 
Statistical analysis 
Physiological data are reported as the mean ± the standard error (SE). The differences 
between the mean values were tested for statistical significance by a one-way ANOVA. P-
values < 0.05 are considered statistically significant. 
Results 
A high-fat diet, but not aging, affects intestinal function and morphology 
To analyze changes in the ability of the intestine of aging mice to respond to a high-fat 
challenge, young and old male C57BL6/J mice were exposed to a control low-fat (10E%) or 
to a high-fat diet (45E%) and sacrificed at the age of 4 and 21 months. The specific diets 
were provided for two weeks since the results of our previous study showed a clear response 
in young mice fed a high-fat diet for this time period [3]. Although body weight of the young 
mice was lower than that of the old mice, both age groups showed a similar and significant 
weight gain after 2 weeks exposure to a high-fat diet (Figure 1A). Both young and old mice 
consumed significantly more energy (E)% on the high-fat diet than on the low-fat diet (Figure 
1B), but no significant difference was found between the two age groups. In addition, 
remnant energy in feces from mice that received the high-fat diet was significantly higher 
than from mice fed the low-fat diet. This effect was also similar in young and old mice 
(Figure 1C). Based on gross energy intake and fecal out-put, we calculated that digestible 
energy uptake was equally efficient in young and old mice (Figure 1D). Taken together, these 
results indicate that the intestine of 21-month-old C57BL/6 J mice is still fully capable in 
absorbing energy from the diet under both a low-fat condition and in response to a high-fat 
dietary challenge. 
Figure 1 Bodyweight development, efficiency of energy intake and small intestinal tissue 
morphology in young and old mice. 4 and 21-month-old mice were exposed to a low-fat or 
a high-fat diet for 2 weeks. (A) Bodyweight, (B) food intake and (C) fecal energy excretion 
were measured. (D) The efficiency of energy up-take was calculated and (E) villi length of 
the proximal, middle and distal part of the intestine in H&E stained paraffin sections was 
compared between young and old mice. In all figure the mean values ± SE were presented, 
young/low-fat n = 6, young/high-fat n = 6, old/low-fat n = 8, old/high-fat n = 8, *p < 0.05 
To perform its unique functions, the intestine requires a highly specialized tissue structure. 
Morphometric analysis of H&E stained sections of the proximal, middle and distal part of the 
small intestine showed, as expected, a marked decrease in villi length in the successive 
segments of the small intestine. However, again no significant differences between old and 
young mice were observed (Figure 1E). In the distal part of the small intestine a small but 
significant increase in villi length was observed after 2 weeks exposure to a high-fat diet in 
both old and young mice. No difference in crypt depth and villi width was found between old 
and young mice in all three parts of the small intestine (data not shown). In the colon, no 
differences between young and old mice in crypt depth on H&E stained sections or in the 
number of proliferating cells as measured by Ki67 staining were observed (data not shown). 
Thus, no changes were found in the functional capacity as well as in the tissue morphology of 
the intestine between 4- and 21- month-old mice. 
Aging-induced changes in gene expression are more pronounced in the colon 
than in the small intestine 
To evaluate the molecular effects of aging, microarray analysis was carried out on RNA 
isolated from scrapings derived of the proximal, middle and distal part of the small intestine 
and of the colon after two weeks of dietary intervention. A fold change threshold (2.0 fold) 
was applied for the identification of differentially expressed genes to determine the most 
prominent changes in gene expression. The results presented in Figure 2A show that in mice 
fed a low-fat diet, aging altered expression of only a limited number of genes in the small 
intestine. However, aging changed expression of a much larger number of genes in the colon, 
under both low-fat and high-fat conditions. In mice fed a high-fat diet the distal part of the 
small intestine showed a relative pronounced aging response, but in the proximal and middle 
segment gene expression between young and old mice turned out to be highly similar. 
Remarkably, while in the colon aging predominantly induced gene expression, in the small 
intestine aging mainly suppressed gene expression. 
Figure 2 Aging-induced differential gene expression in the 3 segments of the small 
intestine and the colon. (A) Differences in basal gene expression between 4- and 21-month-
old mice were calculated for each of the 4 segments of the intestine. The number of genes 
showing over 2-fold differential gene expression observed under either low-fat or high-fat 
dietary conditions are presented in the figure. (B) A comparison of all genes showing 
differential expression in response aging in at least one of on the 4 segments of the intestine 
shows an overlap between the response under low-fat and high-fat conditions. (C) By 
comparing all aging-responsive genes under both low-fat and high-fat conditions a marked 
difference between the proximal, middle and distal part of the small intestine was observed. 
(D) In total, 124 genes were over 2-fold regulated in the small intestine in response to aging 
and 104 genes showed a differential aging response in the colon, 27 of these genes were 
differentially expressed in both segments 
By comparing the total number of differentially expressed genes by aging under low-fat and 
high-fat conditions in all segments of the intestine together we found that most of the genes 
that were over 2-fold regulated in mice fed a low-fat diet were also regulated in mice fed a 
high-fat diet (Figure 2B). Interestingly, a comparison of the 3 segments of the small intestine 
revealed that only 2 genes were over 2-fold regulated in all segments under either low-fat or 
high-fat conditions (Figure 2C). Furthermore, 27 genes were differentially expressed in the 
colon as well as in one or more segments of the small intestine in response to aging (Figure 
2D). However, of these 27 genes 15 were oppositely regulated (see Additional file 1: Table 
S1). 
Increased expression of genes involved in immune response and inflammation 
in the colon of aged mice 
Ingenuity Pathway Analysis (IPA) was applied on the genes showing aging-induced 
differential expression in the colon to obtain insight into which pathways and networks these 
genes contribute to. As can be seen in Figure 3A, the group of genes showing enhanced 
expression in the colon of 21-month-old mice was dominated by genes involved in immune 
response and inflammation. To compare the differential response of this functional category 
between the small intestine and the colon in more detail, we selected all genes involved in 
immune response and inflammation (based on gene ontology) showing over 2-fold 
differential expression in old mice compared to young mice in at least one of the four 
segments of the intestine. The results presented in Additional file 2: Table S2 show a large 
number of genes with increased expression under both low-fat and high-fat conditions 
specifically in the colon of aging mice. Additional file 2: Table S2 and the IPA network 
presented in Figure 3B shows that a large number of IFNγ-responsive genes are present 
amongst the genes displaying enhanced expression in the colon of aging mice. However, 
since basal gene-expression levels of IFNγ itself were below the threshold of our microarray 
analysis in all isolated samples, this gene was not included in the analysis. Q-PCR analysis 
revealed that expression levels of IFNγ in the colon were indeed extremely low, but that 
significantly enhanced expression in response to aging could be observed (Figure 3C). This 
expression pattern is similar to that of two IFNγ responsive genes (IF44 and IF47) that 
showed over 2- fold induction in the colon of old mice (Figure 3C + D). Low grade chronic 
inflammation is a common phenomenon during aging [26]. By applying Q-PCR analysis on 
colon samples of the 4- and 21-month-old mice we found that, in line with our microarray 
results, basal expression of three well-established pro-inflammatory cytokines, TNFα, IL1β 
and IL6 was very low in both young and old mice (Figure 3C + 3D). Enhanced expression of 
TNFα and IL1β was observed in the colon of aging mice while only minor and insignificant 
effects were found for IL6. Taken together it can be concluded that although basal expression 
of various pro-inflammatory cytokines is very low, a significant increase could be observed 
in the colon of aging mice. 
Figure 3 Enhanced expression of genes involved in immune response and inflammation 
in the colon of aging mice. (A) IPA analysis was carried out on the genes showing at least 2-
fold differential expression in the colon of aging mice. Ingenuity Pathway Analysis identified 
Inflammatory response as the major regulated category. Functions within this category are 
shown that were significant with a p-value of at least 0.005 (−log p-value 2.3) and at least 
five genes differentially expressed between old and young mice in the LF group. (B) 
Although INFγ expression was below the threshold level of our microarray data a large 
number of INFγ-responsive genes showed over 2-fold up-regulation in aging mice. (C) Q-
PCR analysis confirmed the up-regulation of the INFγ target genes IF44 and IF47 and 
showed in addition up-regulated expression of INFγ, TNFα and IL-1β but not of IL6 in 21-
month-old mice. (D) Basal expression levels of various genes measured by microarray 
analysis and (E) total number of bacteria present in the lumen of the 4 segments of the 
intestine measured by 16S rRNA Q-PCR in old and young mice under low-fat and high-fat 
conditions. The mean values ± SE were presented, *p < 0.05 
To determine whether the observed changes in expression of genes involved in immune 
response and inflammation were due to alterations in the microflora, 16S rRNA Q-PCR 
analysis was carried out to analyze the total number of bacteria present in the luminal content 
of the three segments of the small intestine and of the colon. The results presented in Figure 
3E show that, as expected, by far the largest number of bacteria was found in the colon, but 
no significant changes in total bacterial content between young and old mice were observed. 
In the distal part of the small intestine a decline in the number of bacteria was found in old 
mice, but this effect was only significant in mice fed a low-fat diet. In addition, relative 
abundance of Bacteriodetes and Firmicutes was measured in the colon to determine changes 
in composition of microbiota. However, no aging-induced changes were observed for these 
dominant phyla (data not shown). 
Together these results indicate that the group of genes showing enhanced expression in the 
colon of aging mice is dominated by genes involved in immune response and inflammation, 
but this effect cannot be explained by changes in the total number of bacteria present in the 
lumen or changes in the Bacteriodetes/Firmicutes ratio. 
Decreased expression of Cubilin in the intestine of aging mice 
The microarray data presented in Figure 2A show that only a limited number of genes are 
differentially expressed in the small intestine of aging mice. In line with the observation that 
energy absorption between young and old mice IPA analyses of the microarray data did not 
reveal aging-induced changes in common metabolic pathways of macronutrients in the small 
intestine. Since micronutrient deficiency is common in the elderly we searched for 
differentially expressed genes involved in micronutrient metabolism. Our microarray data set 
revealed several genes involved in micronutrient metabolism showing differential expression 
in the intestine of aging mice. In 21-month-old mice over 2-fold reduction in the expression 
of Cubilin (Cubn), a gene that mediates the transfer of intrinsic factor-vitamin B12 complex 
across the epithelial membrane, was found in the colon (Figure 4A). These results could be 
validated by Q-PCR analysis (Figure 4B). Also in the proximal and middle part of the small 
intestine of old mice decreased Cubn expression was observed, although these effects were 
less pronounced than in the colon (data not shown). In addition, basal expression of 
cytochrome b reductase 1 (Cybrd1), a gene involved in iron metabolism, and metallothionein 
2 (MT2) involved in zinc and copper metabolism, showed over 2-fold higher expression in 
the small intestine of aging mice. However, since expression of both genes is increased and 
no concomitant differential expression of transporters involved in absorption of these 
minerals was found it is currently not clear whether these effects contribute to altered 
micronutrient metabolism in the intestine of aging mice. 
Figure 4 Effect of aging on Cubn expression in the colon. (A) Microarray analysis and (B) 
Q-PCR analysis revealed decreased expression of Cubn in the colon of aging mice that have 
received either a low-fat or high-fat diet 
In summary, while no major effects on macronutrient metabolism were found in the intestine 
of old mice, our microarray data revealed that micronutrient metabolism might be affected by 
aging due to changes in gene expression in the intestine in aging mice. However, further 
research is required to determine the functional consequences of these changes. 
A high-fat dietary challenge affects gene expression in the small intestine of 
young and old mice 
In addition to the changes in basal gene expression between old and young mice, the 
microarray data were analyzed to compare the ability of the intestine to respond to a high-fat 
dietary challenge between the two age groups. As can be seen in Figure 5A, two weeks 
exposure to a high-fat diet showed, as expected, only a limited effect on gene expression in 
the colon of both young and old mice. A much stronger response to the high-fat diet was 
found in the small intestine where also a differential response between old and young mice 
could be observed. While in young mice the response towards a high-fat diet declined in 
subsequent sections of the small intestine, in old mice the effect became stronger in the more 
distal located parts. An overview of all genes showing over 2-fold change in expression in at 
least one of the 4 segments of the intestine in response to a high-fat dietary challenge is 
presented in Additional file 3: Table S3. 
Figure 5 Differential gene expression induced by a high-fat diet in the 4 segments of the 
intestine. (A) The number of genes showing at least 2-fold up or down-regulation in the 
proximal, middle or distal part of the small intestine or in the colon in 4 and 21-month-old 
mice. (B) IPA analysis revealed the major functional categories to which the differentially 
expressed genes in the small intestine belong 
IPA analysis applied to the genes regulated in response to a high-fat diet in the small intestine 
of young and old mice indicated that, although the number of genes showing over 2-fold 
regulation differed between young and old mice, the same pathways were affected in both 
age groups (Figure 5B and Additional file 4: Table S4). The most pronounced difference in 
the fat response between old and young mice was detected in the proximal part of the small 
intestine. Analysis of the microarray data revealed that in this segment of the small intestine a 
large number of genes involved in immune response and inflammatory processes were down-
regulated in response to a high-fat diet in old mice (see Additional file 3: Table S3). 
Taken together these results imply that although the number of genes over 2-fold regulated by 
a high-fat dietary challenge is different between young and old mice, the same pathways were 
affected in the two age groups. This suggests that the intestine of the old mice seems still 
highly capable in handling a high-fat dietary challenge. 
Decreased global DNA methylation in the intestine of aging mice 
Pyrosequencing of B1 elements, a CpG rich repetitive sequence present in the mouse 
genome, was carried out in DNAs isolated from the same scrapings as used for microarray 
analysis. As can be seen in Figure 6 a significant decrease in global DNA methylation was 
found in the distal part of the small intestine and the colon under both low-fat and high-fat 
conditions in the 21-month-old mice. Also in the proximal part of the small intestine, where 
the methylation status of the B1 element was found to be lower than in the other segments of 
the intestine, decreased methylation of the B1 element was found in 21-month-old mice, 
athough this effect was not significant. No change in global DNA methylation was found in 
the middle part of the small intestine. Furthermore, the results presented in Figure 6 show that 
two weeks exposure to a high-fat diet did not induce significant changes in global DNA 
methylation in young as well as in old mice in all 4 sections of the intestine. 
Figure 6 Global DNA methylation in the 4 segments of the intestine. Pyrosequencing of 
B1 elements in the proximal, middle and distal part of the small intestine and in the colon 
revealed significant global hypomethylation in the distal part of the small intestine and colon 
of aging mice. Mean values ± SE were presented, *p < 0.05 
Discussion 
The importance of appropriate functioning of the gut for the maintenance of health has been 
generally accepted. However, to what extent aging-induced functional decline in the small 
intestine and colon have a causal effect on the impaired health status of the increasing 
number of elderly in our modern Western society is still an unresolved issue. A large number 
of studies have already zoomed in on different features of the aging intestine separately, but 
in this study we have examined functional, structural and molecular effects of aging in the 
mouse small and large intestine. The adult life in C57BL/6 J mice is characterized by 
different phases. The young adult phase starts at 3 and ends at 6 months of age and reflects a 
human age ranging from 20 to 30 years. Mice are considered to be in their old phase when 
they are between 18 and 24 months of age representing a human age ranging from 56 until 69 
years [27,28]. By comparing energy intake between C57BL/6 J mice at the age of 4- and 21-
months, we found no reduction in either the efficiency of energy absorption of the control 10 
E% fat diet or of the 45 E% high-fat diet. The fact that energy intake is not altered in the mice 
implies that capacity to digest and absorb macronutrients by the gastrointestinal tract does not 
decline with age. In line with this observation, our microarray data discloses no significantly 
altered pathways in macronutrient metabolism in aging mice up to the age of 21-months. A 
previous study has analyzed gene expression regulation in the duodenum and colon of aging 
rats [29]. Similar to our findings this study also observed a higher number of differentially 
expressed genes in the colon compared to the small intestine. Furthermore, in agreement with 
our results they found that in the colon, aging caused mainly increased gene expression, while 
in the small intestine most of the differentially expressed genes were decreased. However, 
while in our study the number of altered genes involved in metabolic processes was very low, 
Lee and colleagues reported altered expression of genes involved in nutrient digestion and 
absorption and energy metabolism, although this observation was not further supported by 
additional functional analyses [29]. Differences between aging in rats and mice, different 
segments of the intestine analyzed or the use of scrapings versus whole intestine are factors 
that might contribute to the discrepancy between the obtained results. 
Although we did not observe marked changes in expression of genes involved in 
macronutrient metabolism, changes in expression levels of genes playing a role in 
micronutrient metabolism including Cubn were detected. Cubn is of crucial importance for 
the absorption of vitamin B12 by mediating the transfer of the intrinsic factor-vitamin B12 
complex over the apical membrane of enterocytes [30]. Our microarray data show decreased 
expression of Cubn in the proximal and middle part of the small intestine as well as in the 
colon of aging mice. Vitamin B12 deficiency occurs frequently in elderly humans [31,32] and 
has been shown to play a causal role in a variety of diseases like depression and impaired 
cognition [33,34], cardiovascular diseases [35] and osteoporosis [36,37]. Vitamin B12 
deficiency in the elderly is mainly due to reduced food intake and, predominantly, 
malabsorption. It is believed that insufficient release of vitamin B12 from food and impaired 
coupling to intrinsic factor (IF) due to chronic atrophic gastritis [32] represent the underlying 
mechanisms of the malabsorption. However, our results imply that reduced expression of 
Cubn might contribute to the impaired absorption of vitamin B12 in the intestine and that this 
decreased expression puts the elderly at risk of becoming vitamin B12 deficient. 
While aging-induced molecular responses occurred predominantly in the colon, in contrast, 
the major changes in gene expression induced by a high-fat dietary challenge were found in 
the small intestine. Furthermore, while IPA analysis of the differentially expressed genes 
showed that aging did not cause major changes in metabolic pathways, genes involved in a 
variety of metabolic processes dominated the molecular response induced by the high-fat 
diet, confirming the results of our previous study [3]. Interestingly, exposure to a high-fat diet 
for two weeks resulted in increased villi length in the distal part of the small intestine in 
young and old mice. One could speculate that the capacity of the proximal and middle part of 
the small intestine is insufficient to clear the intestinal content of all lipids and/or fatty acids 
in case of a diet containing 45 E% of fat. As a consequence, the final part of the small 
intestine is exposed to increased amounts of fat affecting the tissue structure in this part of the 
small intestine. The fact that the dietary composition affects tissue morphology of the 
intestine implies that identical nutritional conditions are of crucial importance to analyze 
aging-induced changes in tissue morphology of the intestine. In line with some other studies 
we did not observe aging-induced morphological changes in any of the 4 segments of the 
intestine while other studies reported changes in tissue morphology of the intestine as a 
consequence of aging. The inconsistency in the published data might be explained by 
differences in species used in the different studies or the different age groups that were 
compared. However, part of the diversity in effects might also be caused by artifacts induced 
by differences in the dietary conditions [13,38-41]. 
The increased expression of genes involved in immune response and inflammation observed 
in the colon of the 21-month-old mice points to an affected immune system in this part of the 
intestine of aging mice. This observation is in agreement with the fact that changes in the 
immune system are one of the hallmarks of the aging body. Immunosenescence is the 
functional decline of the adaptive immune system brought on by natural aging whereby 
protection against infection by pathogens and the effectiveness of vaccination decline 
[42,43]. The second aging-induced change in the immune system is called inflammaging 
which is characterized by a low-grade chronic inflammation process that contributes to the 
pathogenesis of many age-related diseases [44-46]. A large variety of cells with a defense 
function are present especially in the lamina propria and the submucosa of the intestine 
accomplishing immune protection via the innate as well as by the adaptive immune response. 
Interestingly, our microarray and Q-PCR data clearly show that activity of both branches of 
the immune system is enhanced in response to aging exclusively in the colon but not in the 
small intestine of old mice. Expression levels of well-established pro-inflammatory cytokines 
like IFNγ, TNFα, IL6 and IL1β turned out to be extremely low in the colon of both old and 
young mice and below the threshold of our microarray analysis. These low expression levels 
are probably due to the fact that these cytokines are predominantly produced by immune cells 
in the mucosa which is a rather low percentage of cells in relation to all cells present in the 
intestinal tissue. Q-PCR analysis confirmed the very low basal expression levels of these pro-
inflammatory cytokines, yet a weak but significant induction of IFNγ TNFα and IL-1β in the 
colon of aging mice was observed. This result suggests that low-grade inflammation might be 
present in the colon of the aging mice in our study, although it should be noted that no altered 
expression of a number of established inflammation markers like Toll-like receptors (TLRs), 
C-type lectin receptors (CLRs) and retinoic acid-inducible receptors (RLRs) [47] was 
detectable. 
Changes in the gut microbiota in terms of composition and functionality during the process of 
aging have previously been reported [19,20,48] and it has been postulated that these changes 
might contribute to the development of immunosenescence and inflammaging [18,49]. To 
establish whether the enhanced expression of genes playing a role in the immune system are 
due to modifications in the microbiota we measured the total number of all bacteria and of the 
two most prominent phyla colonizing the colon, Bacteriodetes and Firmicutes, in the luminal 
content of the colon. We did not observe aging-related changes. More advanced techniques 
like pyrosequencing are required to determine whether total number of bacteria and changes 
in the composition of the microbiota might play a causal role in the observed changed 
expression of immune-related genes in the colon of our aging mice. Although it is difficult to 
assess the physiological consequences of the enhanced expression of genes involved in 
inflammation and immune response, it seems most likely that this effect is important for the 
health status of the aging colon. 
Interestingly, also colorectal cancer, which occurs with increased frequency in the elderly, 
has been related to an altered immune status of the colon [50-52]. The fact that we only found 
increased expression of immune-related genes in the colon, but not in the small intestine is 
intriguing since tumor formation is a very rare event in the small intestine and molecular 
evidence explaining the extreme difference in incidence of tumor formation in the two 
segments of the intestine is currently still lacking. In contrast to what has previously been 
found in the colon of aging rats [22], none of the well-established genetic markers of 
colorectal cancer (i.e. APC, KRAS, p53 etc.) or genes involved in cell cycle arrest and 
apoptosis [53] showed marked differential expression in the colon of the old mice in our 
study. This observation might be related to the fact that colorectal cancer is only a rare 
spontaneous event in C57BL/6 J mice and that specific predisposing mutations [54] or 
carcinogenic agents [55,56] are required to induce colorectal cancer in this mouse strain. 
Apart from genetic events epigenetic modifications have become important markers of tumor 
development, in particular of colorectal tumors [57]. Hypomethylation of repetitive 
sequences is frequently observed in tumor tissue, but is also recognized to be an established 
feature of normal aging tissue [57]. Interestingly, our results show differential demethylation 
between the various segments of the intestine of normal old mice. Since no significant 
demethylation in the proximal part of the small intestine is observed, it can be speculated that 
this part of the intestine is less prone to tumor development. Further research is required to 
prove this hypothesis and to establish whether changes in DNA methylation are responsible 
for the altered levels of gene expression observed in the colon of our aging mice in line with 
what previously has been reported [21]. 
Conclusion 
The results obtained in this study did not reveal aging-induced morphological changes in 
neither the small intestine nor the colon of 21-month-old mice. Furthermore, no decrease in 
macronutrient metabolic functioning of the intestine was detectable. In agreement with these 
observations, the results obtained by microarray analysis indicated that macronutrient 
metabolism seems to function appropriately in old mice. In contrast however, gene 
expression patterns reveal that micronutrient metabolism might be affected in old mice which 
might contribute to some of the micronutrient deficiencies frequently occurring in the aging 
segment of our society. Furthermore, it can be speculated that the decrease in global DNA 
methylation and the altered status of the immune system of the colon might have play a 
causal role in the decreased health status of this organ at old age. 
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Additional file 1 Table S1. All genes differential expressed in one or more segments of the 
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Additional file 2 Table S2. Immune response and inflammatory genes regulated in old mice 
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Additional file 4 Table S4. Genes present in the IAP functional categories presented in 
Figure 5B regulated by a high-fat diet in the distal part of the small intestine in young and old 
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Table 1: Immune response and inflammatory genes regulated in old mice fed a low-fat or high-fat diet
ID LF HF LF HF LF HF LF HF Symbol Gene name
50908 -1.39 -1.03 -1.02 1.20 -1.36 -1.63 2.50 1.34 C1s complement component 1, s subcomponent
11537 1.13 -1.14 1.30 1.04 -1.98 -1.98 -1.10 4.94 Cfd complement factor D (adipsin)
12902 -1.02 -1.23 -1.5 -1.14 1.28 -2.08 2.00 1.33 Cr2 complement receptor 2
20304 1.05 1.09 -1.27 -1.45 -1.22 -1.61 1.83 2.35 Ccl5 chemokine (C-C motif) ligand 5
55985 -1.06 1.26 -1.24 -1.3 -1.24 -2.46 2.87 2.35 Cxcl13 chemokine (C-X-C motif) ligand 13
12767 -1.14 -1.39 -1.1 -1.07 1.1 -2.13 1.89 1.10 Cxcr4 chemokine (C-X-C motif) receptor 4
12491 -1.01 -1.02 1.20 1.27 1.26 1.19 1.62 6.33 Cd36 CD36 antigen
12508 -1.13 -1.19 -1.18 -1.03 -1.24 -2.64 1.64 1.82 Cd53 CD53 antigen
12517 -1.41 1.06 -1.24 -1.01 -1.16 -1.60 1.22 2.29 Cd72 CD72 antigen
16149 1.52 1.26 1.06 1.04 1.02 -1.09 3.86 5.71 Cd74 CD74 antigen 
15985 -1.06 -1.06 -1.08 -1.12 -1 -2.06 1.30 1.85 Cd79b CD79B antigen
12525 1.25 1.12 1.02 -1.16 -1.01 -1.50 2.17 2.08 Cd8a CD8 antigen, alpha chain
12526 1.55 1.17 1.40 -1.03 1.14 -1.04 2.45 2.17 Cd8b1 CD8 antigen, beta chain 1
26366 1.34 1.3 2.08 1.4 1.56 1.16 1.61 1.26 Ceacam10 carcinoembryonic antigen-related cell adhesion mol 10
13034 -2.11 -1.66 1.07 1.02 -1.23 1.02 1.40 1.42 Ctse cathepsin E
80861 1.12 1.49 1.13 1.21 -1.02 -1.31 1.72 2.12 Dhx58 DEXH (Asp-Glu-X-His) box polypeptide 58
11770 -2.14 -1.44 1.27 -1 -1.89 -1.69 1.23 6.99 Fabp4 fatty acid binding protein 4, adipocyte
14960 1.44 1.20 1.10 1.04 1.03 -1.12 4.38 2.90 H2-Aa histocompatibility 2, class II antigen A, alpha
14961 1.42 1.27 1.08 1.00 -1.04 -1.18 3.41 2.87 H2-Ab1 histocompatibility 2, class II antigen A, beta 1
14998 1.38 1.27 1.12 1.16 -1.11 -1.30 2.21 1.85 H2-DMa histocompatibility 2, class II, locus DMa
15000 1.25 -1.02 1.04 -1.03 1.15 -1.61 2.04 2.73 H2-DMb2 histocompatibility 2, class II, locus Mb2
14969 1.36 1.16 1.12 1.00 -1.00 -1.16 2.99 2.79 H2-Eb1 histocompatibility 2, class II antigen E beta
99899 1.22 1.64 1.04 1.06 2.81 -1.02 4.45 5.97 Ifi44 interferon-induced protein 44
15953 1.08 1.21 -1.01 -1.04 -1.00 -1.34 2.15 1.94 Ifi47 interferon gamma inducible protein 47
15957 -1.06 1.54 -1.17 1.02 1.15 -1.14 2.29 2.21 Ifit1 interferon-induced protein with tetratricopeptide repeats 1
15958 1.08 1.42 -1.29 -1.00 1.75 -1.13 3.29 2.15 Ifit2 interferon-induced protein with tetratricopeptide repeats 2
15959 -1.11 1.78 -1.24 1.13 1.28 1.02 1.99 2.35 Ifit3 interferon-induced protein with tetratricopeptide repeats 3
66141 -1.2 -1.16 1.16 1.17 1.07 -2.33 1.92 1.13 Ifitm3 interferon induced transmembrane protein 3
16145 1.13 1.46 1.19 -1.19 1.27 -1.22 2.17 2.99 Igtp interferon gamma induced GTPase
16069 -1.23 -1.01 -1.14 1.1 -1.54 -2.02 2.95 2.09 Igj immunoglobulin joining chain
692165 -1.33 1.47 -1.42 1.98 -1.30 -1.24 3.02 2.21 Igkv10-96 immunoglobulin kappa chain variable
16098 -1.24 1.93 1.68 3.07 1.81 -1.02 7.95 3.46 Igkv1-117 immunoglobulin kappa chain variable 1-117
692245 -2.18 1.34 -1.92 1.53 -2.31 -1.49 1.78 1.36 Igkv12-46 immunoglobulin kappa chain variable 12-46
667899 -2.49 -1.09 -2.17 1.48 -2.32 -1.78 6.42 2.35 Igk-V19-13 immunoglobulin kappa chain variable 19 (V19)-13
108022 -1.16 -1.03 -1.39 -1.03 -1.64 -1.96 4.78 2.60 Igk-V19-15 immunoglobulin kappa chain variable 19 (V19)-15
692161 -1.84 -2.71 -1.48 -1.93 -2.19 -8.14 2.95 1.71 Igkv19-93 immunoglobulin kappa chain variable 19-93
667928 -2.42 1.27 -1.51 1.39 -1.41 -1.76 BT BT Igk-V21-9 immunoglobulin kappa chain variable 21 (V21)-9
16177 -2.09 -1.36 -1.2 1.04 -1.11 1.13 1.17 -1.09 Il1r1 interleukin 1 receptor, type I
16186 -1.02 -1.08 -1.18 -1.08 -1.21 -2.24 1.75 1.51 Il2rg interleukin 2 receptor, gamma chain
16197 1.32 1.25 1.42 1.32 1.60 -1.00 2.11 1.89 Il7r interleukin 7 receptor
16956 -1.38 -1.15 1.15 1.34 -1.72 -1.05 -1.45 2.63 Lpl lipoprotein lipase
110454 -1.35 -1.27 -1.07 1.07 2.04 -2.74 1.51 1.07 Ly6a lymphocyte antigen 6 complex, locus A
17068 -1.23 -1.13 -1.15 -1 -1.02 -2.02 1.49 1.51 Ly6d lymphocyte antigen 6 complex, locus D
17084 -1.32 -1.16 -1.24 1.08 1.09 -2.47 2.48 2.15 Ly86 lymphocyte antigen 86
17110 -1.13 -1.21 -1.01 -1.11 -1.06 -1.27 1.98 2.07 Lyz1 lysozyme 1
17105 -1.21 -1.17 -1.06 -1.06 -1.08 -1.54 2.51 2.12 Lyz2 lysozyme 2
17224 -1.02 -1.16 1.09 -2.18 1.31 -1.95 1.03 -1.12 Mcpt1 mast cell protease 1
17476 -1.39 -1.26 1.06 1.23 1.11 -1.47 2.42 1.69 Mpeg1 macrophage expressed gene 1
12482 1.02 1.1 -1.18 -1.22 1.13 -3.5 -1.19 -1.06 Ms4a1 membrane-spanning 4-domains, subfamily A, member 1
12482 1.26 -1.06 -1.12 -1.20 -1.03 1.29 2.08 2.06 Ms4a1 membrane-spanning 4-domains, subfamily A, member 1
17858 1.01 2.15 1.12 1.03 -1.75 1.14 BT BT Mx2 myxovirus (influenza virus) resistance 2
18126 -1.2 -2.31 -1.05 -4.13 -1.17 1.05 1.09 1.23 Nos2 nitric oxide synthase 2, inducible
246730 -1.05 1.45 -1.03 -1.53 1.08 -1.49 1.54 2.63 Oas1a 2'-5' oligoadenylate synthetase 1A
23962 1.02 1.21 -1.05 1.08 1.41 1.03 3.35 4.07 Oasl2 2'-5' oligoadenylate synthetase-like 2
18414 -1.47 -1.11 1.06 1.08 -1.17 -1.29 2.22 1.20 Osmr oncostatin M receptor
67709 1.18 1.27 1.03 1.09 -1.01 -2.09 1.19 1.31 Reg4 regenerating islet-derived family, member 4
58185 -1.05 1.94 -1.23 -1.12 1.18 -1.04 2.06 2.31 Rsad2 radical S-adenosyl methionine domain containing 2
20208 1.19 1.15 -1.95 -4.06 -5.83 -5.11 -1.27 1.27 Saa1 serum amyloid A 1
20716 BT BT BT BT BT BT 1.96 2.26 Serpina3n serine (or cysteine) peptidase inh., clade A, member 3N
12258 -1.88 -1.43 -1.19 1.03 -1.14 -2.03 1.67 1.34 Serping1 serine (or cysteine) peptidase inh., clade G, member 1
19073 -1.08 -1.15 1.01 -1.13 -1.06 -2.04 2.08 1.98 Srgn serglycin
21354 -1.01 -1.13 -1.06 1.03 -1.18 -1.03 1.85 2.18 Tap1 transporter 1, ATP-binding cassette, sub-family B
BT: basal expression below threshold
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